Asparaginase Erwinia VON GOTT®
Presentation
Lyophilized Powder for reconstitution into Injectable Solution.
10,000 IU Vial.
Route of Administration: I.V. / I.M.
The use of Asparaginase Erwinia is contraindicated in the following cases:
✓ In patients with severe hypersensitivity reactions to Asparaginase Erwinia chrysanthemi, including anaphylaxis.
✓ In patients who have presented the following adverse reactions, after treatment with Asparaginases derived from E. Coli:
- Severe pancreatitis.
- Severe thrombosis.
- Serious bleeding events.
The specialist will evaluate each case and the risk or benefit of continuing or not with Asparginase therapy.
This website is intended solely for informational purposes for healthcare professionals. At no time is self-medication encouraged without the medical prescription of a healthcare professional.